Pharma BD Deal Intelligence

Celgene Corporation / Receptos Inc.

2015 · Acquisition/Merger · $7.2B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

63

Largely worked — most objectives met.

Celgene acquired Receptos for $7.2B for ozanimod.

Key facts

Announced Jul 14, 2015
Closed Aug 27, 2015
Deal value $7.2B
Deal type Acquisition/Merger
Therapeutic area Gastroenterology, Immunology, Neurology
Key assets ozanimod

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals